IDEAYA Biosciences recently completed full enrollment of 435 patients in its registration-enabling Phase 2/3 OptimUM-02 trial testing oral PKC inhibitor darovasertib plus Pfizer’s crizotinib in ...
A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...
A recent large-scale study has produced results that may challenge assumptions on Covid-19 vaccination. Examining health ...
Morgan Stanley ($MS) has issued a less optimistic outlook on the performance of the shares of American pharmaceutical giant ...
Citing topline data from its Phase 3 TRIUMPH-4, the Indiana-based drugmaker said that retatrutide, a GIP, GLP-1, and glucagon triple hormone receptor agonist, at the two highest doses led to ...
On December 14, 2020 I became the first person in the United States to receive the first FDA-approved COVID-19 vaccine. Now, ...
On Dec. 14, 2012, a gunman killed 27 people, including 20 children at Sandy Hook Elementary School in Newtown, Conn., then ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback